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Abstract
Background: Neuroinflammation following acute brain trauma is considered to play a prominent
role in both the pathological and reconstructive response of the brain to injury. Here we
characterize and contrast both an acute and delayed phase of inflammation following experimental
penetrating ballistic brain injury (PBBI) in rats out to 7 days post-injury.
Methods: Quantitative real time PCR (QRT-PCR) was used to evaluate changes in inflammatory
gene expression from the brain tissue of rats exposed to a unilateral frontal PBBI. Brain
histopathology was assessed using hematoxylin and eosin (H&E), silver staining, and
immunoreactivity for astrocytes (GFAP), microglia (OX-18) and the inflammatory proteins IL-1β
and ICAM-1.
Results: Time course analysis of gene expression levels using QRT-PCR indicated a peak increase
during the acute phase of the injury between 3–6 h for the cytokines TNF-α (8–11 fold), IL-1β (11–
13 fold), and IL-6 (40–74 fold) as well as the cellular adhesion molecules VCAM (2–3 fold), ICAM-
1 (7–15 fold), and E-selectin (11–13 fold). Consistent with the upregulation of pro-inflammatory
genes, peripheral blood cell infiltration was a prominent post-injury event with peak levels of
infiltrating neutrophils (24 h) and macrophages (72 h) observed throughout the core lesion. In
regions of the forebrain immediately surrounding the lesion, strong immunoreactivity for activated
astrocytes (GFAP) was observed as early as 6 h post-injury followed by prominent microglial
reactivity (OX-18) at 72 h and resolution of both cell types in cortical brain regions by day 7.
Delayed thalamic inflammation (remote from the primary lesion) was also observed as indicated by
both microglial and astrocyte reactivity (72 h to 7 days) concomitant with the presence of fiber
degeneration (silver staining).
Conclusion: In summary, PBBI induces both an acute and delayed neuroinflammatory response
occurring in distinct brain regions, which may provide useful diagnostic information for the
treatment of this type of brain injury.
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Background
The brain has been traditionally described as an
"immune-privileged" organ due to its isolation from the
peripheral immune system by the blood-brain barrier
(BBB). However, recent brain injury studies have indi-
cated that resident brain cells are capable of synthesizing
a wide variety of pro-inflammatory mediators necessary
for mounting a neuroinflammatory response [1]. Injury to
the brain induces expression and release of small BBB per-
meable cytokines and chemokines that can stimulate the
peripheral immune system and attract peripheral inflam-
matory leukocytes to the site of injury [2]. Cytokine-medi-
ated intracellular signalling also induces expression of
intercellular adhesion molecules and stimulation of cere-
bral leukocyte infiltration across the BBB [3,4]. Leukocyte
accumulation within the injured brain has been pur-
ported to contribute to the injury process due to release of
cytotoxic substances including reactive oxygen species and
other pro-inflammatory mediators [2]. Although phago-
cytic clearing of cellular debri is inherent to the natural
healing process, release of pro-inflammatory molecules
can potentially induce further stress to the already com-
promised penumbral regions of the injured brain (i.e.
bystander injury) in a feed-forward cascade of inflamma-
tory cell-mediated injury [2,5].
Aside from stimulation of the peripheral immune system,
brain injury induces activation of resident glial cells that
participate in the inflammatory response. In particular,
microglial cells are strongly activated following injury and
play an important role in phagocytosis of injured brain
tissue [6]. Other cells such as astrocytes are also activated
exhibiting a hallmark increase in glial fibrillary acidic pro-
tein (GFAP) expression [7]. Astrocytes are known to be a
source of pro-inflammatory cytokines [8] and in the
advanced stages of injury progression form a glial scar
inhibitory to neural regeneration [9]. However, reactive
astrocytes generally serve a protective role during the early
stages of injury and are responsible for maintaining phys-
iological homeostasis and free radical elimination during
periods of energy deprivation [7,10].
The current research focuses on the neuroinflammatory
response out to 7 days following a penetrating ballistic-
like brain injury in the rat [11-13] out to 7 days following
the initial insult. Results indicate 1) a rapid upregulation
of pro-inflammatory cytokine and cell adhesion molecule
genes within the first few hours post-injury, 2) both an
acute and delayed inflammatory cell response occurring
in distinct brain regions 3) a differential temporal profile
of astrocyte as compared to microglial activation, 4) a dis-
tinct glial response in the thalamus predictive of delayed
fiber degeneration within this same region. We conclude
that PBBI involves a robust neuroinflammatory response
that may help guide the potential management of this
type of injury.
Methods
Male Sprague-Dawley rats (250–300 g; Charles River Labs,
Raleigh, VA) were used in all studies. All procedures were
approved by the Walter Reed Army Institute of Research
Animal Care and Use Committee. Research was con-
ducted in compliance with the Animal Welfare Act and
other federal statutes and regulations relating to animals
and experiments involving animals and adhered to prin-
ciples stated in the Guide for the Care and Use of Labora-
tory Animals, NRC Publication, 1996 edition. Animals
were housed individually under a 12 h light/dark cycle
(lights on at 0600) in a facility accredited by the Associa-
tion for Assessment and Accreditation of Laboratory Ani-
mal Care International.
Penetrating ballistic brain injury model
The Dragonfly Model # HPD-1700 Variable Pressure
Waveform Generator and rat PBBI probe (Dragonfly Inc.,
WV) were used to simulate a right frontal ballistic injury
of a high-velocity 7.62 mm North Atlantic Treaty Organi-
sation (NATO) round to the rat brain [11]. In brief, rats
were anesthetized (2% isoflurane delivered in oxygen)
and positioned in a stereotaxic frame for probe insertion
(Kopf, Tujunga, CA). Body temperature was maintained
normothermic (37 ± 1°C) throughout the surgical proce-
dure by means of a homeothermic heating system (Har-
vard Apparatus, South Natick, MA). The scalp was incised
along the mid-line and a 1 mm diameter burr hole was
created to expose the right frontal pole of the brain (+4.5
mm AP, +2 mm ML to bregma). The PBBI probe was
mounted to a stereotaxic arm and fixed at an angle of 50
degrees from vertical and 25 degrees counter-clockwise
from the anterior-posterior axis. The probe was then
advanced with a micromanipulator (~2 mm/s) along this
axis through the cranial window into the right frontal cor-
tex, through the dorsal aspect of the caudate putamen,
and into the amygdalar region of the brain. The tip of the
PBBI probe travelled a total distance of 1.2 cm from the
surface of the brain.
A 10% severity level of injury was used in the current
study, which represents a moderate-severe but survivable
level of injury associated with consistent and reproducible
histopathological damage [11,13]. PBBI was induced by
delivery of a pressure pulse to rapidly inflate and deflate
the PBBI balloon (to a diameter of 6.33 mm, equal to 10%
of total rat brain volume). Immediately following infla-
tion, the probe was manually retracted from the brain, the
cranial opening sealed with sterile bone wax, and the inci-
sion closed with 4-0 nylon suture followed by administra-
tion of a topical antibiotic. Following surgery, animals
were placed in a warm chamber maintained by a circulat-Journal of Neuroinflammation 2007, 4:17 http://www.jneuroinflammation.com/content/4/1/17
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ing water-bath heating system (Gaymar Indust., Orchard
Park, NY) until recovery from anesthesia. Food and water
were provided ad libitum post-operatively. Sham animals
were not subjected to probe insertion but otherwise
received all surgical manipulations.
Histopathology
At the indicated post-injury endpoint, animals were anes-
thetized with ketamine/xylazine (70 and 6 mg/kg, i.p.,
respectively) and transcardially perfused with phosphate
buffered saline (PBS; pH 7.4 at room temperature) fol-
lowed by ice-cold 4% paraformaldehyde. Brains were
extracted, immersed in 4% paraformaldehyde for 6 h and
then transferred to 0.1 M phosphate buffer containing
20% sucrose (pH 7.4, 4°C). All brain tissue was sent to FD
Neurotechnologies (Baltimore, MD) for histopathologi-
cal staining.
Coronal brain sections (40 μm thick) were cut through
the cerebrum from +4.0 to -7.0 mm AP to bregma with
serial sections collected at 1 mm intervals. Silver staining
was performed using the FD Neurosilver™ Kit I (FD Neu-
roTechnologies, Baltimore, MD) according to the manu-
facturer's instructions to detect fiber degeneration.
Hematoxylin & eosin (H&E) was used for morphological
assessment of injury and detection of inflammatory cells
including polymorphonucleocytes (neutrophils), mono-
cytes, and macrophage-like cells (defined by large irregu-
lar cytoplasm) [14]. Antibodies against OX-18 were used
for detection of activated microglia and GFAP for detec-
tion of activated astrocytes [11]. In brief, following inacti-
vation of endogenous peroxidase activity, biotin, biotin-
binding proteins, and lectins, sections were incubated
free-floating in PBS containing 1% normal horse serum
(Vector Labs, Burlingame, CA), 0.3% Triton X-100
(Sigma, St. Louis, MO) and polyclonal rabbit anti-cow
GFAP IgG (1:20,00; Z0334, DAKO, Glostrup, Denmark)
or monoclonal mouse anti-OX18 IgG (1:6,000; MCA51R,
Serotec, Raleigh, NC) for 3 days at 4°C. The immunoreac-
tion product was then visualized according to the avidin-
biotin complex method of Hsu et al. (1981) [15] with
Vectastin Elite ABC kit (Vector Laboratory, Burlingame,
CA). After dehydration in ethanol and clearing in xylenes,
all sections were coverlipped in Permount® (Fisher Scien-
tific, Fair Lawn, NJ). All tissue samples were evaluated by
light microscopy.
Tissue processing for gene expression studies
At each given endpoint, rats were deeply anesthetized
with ketamine/xylazine (70 and 6 mg/kg, i.p., respec-
tively) and brains harvested for analysis. A 2 mm section
was dissected from the core lesion of each rat brain (1–3
mm anterior to bregma, as shown in Figure 1), divided
into hemispheric sections contralateral and ipsilateral to
the primary injury, rapidly frozen on dry ice, and stored at
-70°C until RNA extraction. Frozen brain tissue was
homogenized in QIAzol ™ lysis reagent and total RNA
extracted using Qiagen RNeasy Liquid Tissue Mini Kit
according to the manufacturer's instructions (Qiagen Sci-
ence, Germantown, MD). RNA purity and concentration
were determined spectrophotometrically by calculating
the ratio between the absorbance at 260 nm and 280 nm.
The absorbance ratio for all samples ranged between 1.8
and 2.1. The quality of RNA for all samples was confirmed
by resolving on a 1.5% formaldehyde agarose gel.
Real time (RT)-PCR
Quantitative RT-PCR was performed with ABI Prism 7000
sequence detection system (PE Applied Biosystems) as
previously described [16] using TaqMan™ Universal PCR
Master Mix (AB  Applied Biosystems) as per manufac-
turer's specifications. Amplification conditions included 2
minutes at 50°C and 10 minutes at 95°C, and then run
for 40 cycles at 95°C for 15 seconds and 60°C for 1
minute. PCR primers and TaqMan™ probes were designed
using Primer Express 2.0 Software and synthesis was per-
formed by AB  Applied Biosystems. Primer/probe
sequences used are as previously reported [16]. Data are
presented as relative induction of each cytokine or cellular
adhesion molecule normalized to ribosomal protein L32
(RPL32).
Statistical analysis
Quantitative data (i.e. RT-PCR gene expression levels)
were analyzed using paired t-tests between the ipsilateral
and contralateral brain hemispheres. The contralateral
hemisphere served as an internal control for each brain
sample. Data are presented as mean ± standard deviation.
P values < 0.05 were considered significant.
.
Results
General pathology
PBBI induced a unilateral lesion to the right brain hemi-
sphere predominately involving the frontal cortex and
striatum. A hemorrhagic core lesion developed along the
injury track reaching maximal size by 24–72 h with for-
mation of an intracranial cavity by day 7 post-injury (Fig.
1).
Inflammatory gene expression profile
QRT-PCR was used to verify and track the time course
changes of 3 cytokine (TNF-α, IL-1β, and IL-6) as well as
3 cellular adhesion molecule (ICAM-1, VCAM, and E-
selectin) mRNA levels following PBBI (Fig. 2). These spe-
cific inflammatory genes were chosen for direct compari-
son to previously published time course data in a rat focal
brain ischemia model using the same QRT-PCR primer
and probes [16].Journal of Neuroinflammation 2007, 4:17 http://www.jneuroinflammation.com/content/4/1/17
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All 6 inflammatory genes were significantly up-regulated
between 3–12 h post-injury with peak expression levels
occurring between 3–6 h. The increase in expression sub-
sided by 24–72 h post-injury. Peak increases in gene
expression as compared to sham tissue were as follows:
TNF-α (8–11 fold), IL-1β (11–13 fold), IL-6 (40–74 fold),
VCAM (2–3 fold), ICAM-1 (7–15 fold), and E-selectin
(11–13 fold). In comparison to focal ischemic brain
injury, inflammatory gene expression exhibited elevated
and more rapid increases in mRNA expression levels, as
indicated by IL-1β and ICAM-1 (Fig. 3).
Changes in IL-1β and ICAM-1 expression were also veri-
fied by immunostaining brain tissues with antibodies for
the respective proteins. IL-1β immunoreactive cells dem-
onstrated dark nuclear and cytoplasmic staining including
ramified processes typical in morphology to glial cells
(Fig. 3). In contrast, ICAM-1 expression was restricted to
vascular cells also surrounding lesion sites (Fig. 3).
Inflammatory cell response (H&E)
The normal (sham) rat brain did not exhibit any distinc-
tive evidence of inflammatory cell infiltrate (Fig. 4A). In
the PBBI animals, intravascular neutrophil clustering
appeared as early as 6 h post-injury (Fig. 4B) surrounding
the primary lesion site with migration of neutrophils into
the core lesion by 24–72 h (Figure 4C). By 72 h, parenchy-
mal monocytes/macrophages were the dominant cell
observed throughout the core lesion (Figure 4D). By day
7 most of the inflammatory infiltrate was confined to the
immediate region of the primary lesion site (Figure 4E)
along with a band of reactive gliosis (Figure 4F).
Gliosis (astrocytes and microglia)
Activated microglia appeared as highly ramified cells reac-
tive for OX-18 (Fig. 5). In the peri-lesional regions of the
cortex and striatum, microglia exhibited immunoreactive
processes starting 24 h post-injury with maximal activa-
tion and "bushy" morphology by 72 h with almost com-
plete resolution by day 7 (Fig. 5) except for a strong band
of reactivity immediately surrounding the lesion at day 7.
The peri-lesional region also exhibited the presence of
highly ramified GFAP-immunoreactive astrocytes with a
more rapid post-injury expression profile as compared to
microglial activation (Fig. 5 & Table 1). Strongly reactive
astrocytes with hypertrophic soma and thick processes
were observed as early as 6 h post-injury with a progres-
sive increase in cell density out to 72 h (Fig. 5). By day 7,
the peri-lesional regions were sparsely reactive for astro-
cytes with a similar band of reactive cells immediately sur-
rounding the lesion (Figs. 4F &5) as observed for
microglia. The GFAP and OX-18 images shown in Fig 5 are
from the same animal at each respective time point (4–6
animals were evaluated at each post-injury time point).
Delayed thalamic inflammation
There was no histologic evidence of injury in the ipsilat-
eral hemisphere remote from the core lesion or in the con-
tralateral hemisphere through 24 h following PBBI.
However, fiber degeneration (silver staining) became
apparent by 72 h in remote ipsilateral brain regions such
as the thalamus (Fig. 6), internal capsule, and cerebral
peduncle and was associated with strong glial reactivity
(Fig. 6). In particular, at the early stages of fiber degenera-
tion in the thalamus, GFAP reactive cells were notable (72
h) and remained through day 7 (Figure 6). In contrast, the
presence of activated microglia was minimal at 72 h and
became prominent by day 7, particularly in regions of
intense silver reactivity (Fig. 6).
PBBI histopathology Figure 1
PBBI histopathology. Time course change in brain pathology following PBBI (H&E) leading to eventual formation of a large 
intracranial cavity by day 7 post-injury. Representative coronal sections (1 mm anterior to bregma) are shown from the ipsilat-
eral hemisphere following PBBI in rats.
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Inflammatory gene expression Figure 2
Inflammatory gene expression. Change in mRNA expression levels of 6 pro-inflammatory genes in injured brain tissue 
from 3 to 72 h following PBBI (QRT-PCR). Data presented as mean ± standard deviation (n = 3/group). * P < 0.05 as compared 
to contralateral hemisphere.
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Discussion
The current data indicate that PBBI induces a biphasic pat-
tern of neuroinflammation in anatomically distinct
regions of the brain, progressing from the site of the "pri-
mary lesion" to a "delayed injury" occurring in remote
brain structures such as the thalamus. The acute neuroin-
flammatory response was associated with upregulation of
pro-inflammatory cytokines and cellular adhesion mole-
cules with peak increases in mRNA levels between 3–6 h
post-injury followed by inflammatory cell activation and
recruitment into the primary lesion. The early post-injury
upregulation of cytokines such as IL-1β appeared to occur
predominately in glial-type cells, corresponding to the
early activation of astrocytes. Vascular expression of cellu-
lar adhesion molecules (e.g. ICAM-1) likely contributed
to the intravascular collection of peripheral neutrophils
by 6 h [17], a possible pathological response leading to
further injury due to microvascular occlusion [3]. Inflam-
matory cell infiltrate was notable in the ensuing post-
injury days and by 72 h a dense phagocytic infiltrate was
present within the primary lesion surrounded by a maxi-
mal expression of activated cortical/striatal microglia. By
day 7 the primary lesion was largely resolved, replaced by
an intracranial cavity and surrounded by a rim of strong
glial reactivity. In contrast, a second phase of neuroin-
flammation occurred in the thalamus as indicated by glial
cell activation, concomitant with an extensive degree of
fiber degeneration in this region.
The rapid increase in inflammatory gene expression fol-
lowing PBBI may have significant implications on the
therapeutic management of this type of neuroinflamma-
tory response. In comparison, previous studies from our
own lab have indicated a delayed increase in pro-inflam-
matory gene expression induced by 2 h of transient mid-
dle cerebral artery occlusion (MCAo) in rats with peak
increases between 6–24 h for the same pro-inflammatory
genes evaluated in the current study [16]. The rapid acti-
vation of cytokine gene upregulation appears to be more
pronounced in traumatic versus ischemic type injuries as
demonstrated with PBBI and supported by data from
other rat TBI studies [18-21]. In particular, both IL-1β and
TNF-α mRNA levels have been shown to peak 1–3 h fol-
lowing experimental TBI in rats (Fan, 1996)[20,21]. The
clinical implication for these differences in inflammatory
gene expression between traumatic versus ischemic injury
may be dramatic. For example, attenuation of the nuclear
factor  κB (NF-κB) mediated pro-inflammatory gene
IL-1β and ICAM-1 immunoreactivity Figure 3
IL-1β and ICAM-1 immunoreactivity. IL-1β was most 
notable in ramified cells surrounding the lesion (upper panel). 
ICAM-1 was only observed in the vasculature surrounding 
the immediate lesion track (lower panel). Bar = 100 μm
IL-1E
ICAM-1
Table 1: Glial cell reactivity
Time Point GFAP OX-18
Sham 00
6 h + + +
24 h + + +
72 h + + + + + +
7 days ++
Degree of immunoreactivity for astrocytes (GFAP) and microglial cells (OX-18) in brain tissue surrounding primary PBBI lesion (0 = none, + 
minimal, + + moderate, and + + + strong reactivity). Based on evaluation of 4–6 animals per post-injury time-point.Journal of Neuroinflammation 2007, 4:17 http://www.jneuroinflammation.com/content/4/1/17
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Inflammatory leukocyte infiltration Figure 4
Inflammatory leukocyte infiltration. Neutrophils (black arrows) were present as early as 6 h post-injury lining vessel walls 
(B, H&E) with intraparenchymal invasion by 24 h and beyond (C, H&E) as compared to sham tissue (A, H&E). A dense array of 
large macrophage-like cells (white arrows) were prominent by 72 h, particularly along the immediate border of the PBBI lesion 
(D, H&E). By day 7 an intracranial cavity had formed surrounded by a dense cellular infiltrate (E, H&E) and large, highly ramified 
astrocytes (F, GFAP). Bar = 20 μm (A-D), 100 μm (E-F).
A B
C
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cavity cavityJournal of Neuroinflammation 2007, 4:17 http://www.jneuroinflammation.com/content/4/1/17
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response through proteasome inhibition offers a signifi-
cant neuroprotective recovery from transient MCAo in rats
[22,23]. Importantly, the 6–10 h therapeutic treatment
window associated with proteasome inhibition in the
MCAo model directly correlated to peak levels of inflam-
matory gene expression [24-26]. Given the rapid increase
in inflammatory gene expression following PBBI, we
would hypothesize that neuroprotection therapies target-
ing the neuroinflammatory gene response (e.g. regulators
of NF-κB activity), would offer a shorter therapeutic win-
dow as compared to focal ischemic injury, thereby requir-
ing quicker therapeutic intervention.
Another interesting aspect of this study was the differen-
tial response of astrocytes and microglia to PBBI. In the
cortical regions surrounding the primary lesion astrocytes
were rapidly activated and remained strongly reactive
through 72 h post-injury. In contrast, microglia were
slower to react and did not become fully reactive until 72
h post-injury. A similar but delayed pattern of glial cell
activation was observed in the thalamus as well with max-
imal reactive astrogliosis occurring at 72 h post-injury fol-
lowed by maximal microglial activation at day 7. These
data would suggest fundamentally different roles for these
two types of cells in response to brain injury possibly reac-
tive to distinct triggering mechanisms (as discussed
below). Although the presence of glial activation in the
injured brain certainly represents a disturbance of normal
brain physiology or predictor of a pathological condition,
it is still controversial as to whether reactive gliosis is
harmful or beneficial to the acutely injured brain [27,28].
The rapid activation of astrocytes surrounding the primary
PBBI lesion likely reflects a response to the upregulation
Inflammatory gliosis Figure 5
Inflammatory gliosis. Representative coronal brain sections (1 mm anterior to bregma) indicating the time course change in 
activated microglial cells (OX-18 immunoreactivity) and reactive astrogliosis (GFAP immunoreactivity) surrounding the pri-
mary lesion site. Bar = 100 μm.
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of cytokine signalling [27] but may also be aggravated by
changes in the extracellular matrix such as increases in K+
due to peri-infarct depolarizations, a common phenome-
non following PBBI [11]. Astrocytes react to changes in
the extracellular environment through uptake of extracel-
lular glutamate, K+ buffering, and elimination of free rad-
icals which may be crucial for neuronal survival during
the acute post-injury period [7,10]. Astrocytes, in general,
are more resistant than neurons during periods of energy
failure or following toxic insult. However, overextension
Delayed inflammation Figure 6
Delayed inflammation. Delayed inflammatory response of the thalamus to PBBI. Both activated astrocytes (GFAP) and 
microglial cells (OX-18) were observed from 72 h to 7 days post-injury and corresponded to an increase in fiber degeneration 
(silver staining). Bar = 100 μm.
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of the protective capability of the astroglial response will
ultimately lead to cell death. In fact, injury-induced astro-
cytic swelling is responsible for production and release of
excitotoxic agents including quinolinic acid and gluta-
mate and ultimately a loss of normal homeostatic func-
tion that may exacerbate neuronal damage [28,29]. Direct
astrocytic malfunction or loss of viability has been cou-
pled to the subsequent death of neurons within the sur-
rounding environment [30].
In contrast to astrocyte activation, widespread microglial
reactivity in cortical regions surrounding the primary
lesion was not observed until 72 h following PBBI. The
triggering mechanism for this delayed response is
unknown, although it does correspond to the mass migra-
tion of large amaeboid macrophages into the primary
lesion site. Microglial cells are the resident macrophages
of the CNS of myeloid origin that can exhibit a wide spec-
trum of stimulus-specific responses [31]. Specifically,
microglial cells become activated through cell-surface
stimulation of toll-like receptors [31], ultimately leading
to the phagocytic activity of these cells, but are also mod-
ulated through activation of purinergic [32,33] and CD40
receptors [34]. Similar to astrocytes, microglia may be
beneficial or harmful to the injured brain depending on
their specific environmental context including degree and
length of activation or post-injury time point of reactivity.
Microglia can be beneficial to the injured brain through
production of trophic factors and phagocytic resolution of
the lesion [30] although production of pro-inflammatory
cytokines and reactive oxygen species may be harmful to
surrounding tissues [31]. The definitive role of microglia
in the injured brain remains to be elucidated although
experimental therapies that reduce microglial reactivity
following PBBI have been associated with improved path-
ological and functional outcome [35].
Two distinct and divergent temporal neuroinflammatory
profiles were also captured with the PBBI model. The first
being the rapid neuroinflammatory response within the
core lesion characterized by a strong gliotic response cou-
pled with mass infiltration of peripheral inflammatory
cells. In contrast, the neuroinflammatory response in the
thalamus involved primarily a gliotic response void of the
marked infiltration of peripheral inflammatory cells as
seen in the primary lesion. Delayed thalamic degenera-
tion, similar to that observed following PBBI, has also
been observed in other focal brain injury models includ-
ing injuries induced by cortical ablation, infarction, or
trauma [11,36-40]. Similarly, loss of thalamic volume has
been observed in human stroke and TBI patients exhibit-
ing cortical lesions [41,42]. This pattern of delayed tha-
lamic injury and associated neuroinflammatory response
is of particular interest as it represents a delayed target of
neuroprotective intervention aimed at preserving tha-
lamic integrity and improving patient outcome [39]. In
particular, GFAP may hold promise as a potential thera-
peutic biomarker of delayed brain injury as it is expressed
prior to thalamic injury, as indicated following PBBI, and
is specific for glial cells of the CNS [43]. Increases in GFAP
concentrations have been observed in CSF samples fol-
lowing human stroke [44] and in blood samples of severe
TBI patients [45] although expression has not be corre-
lated to delayed injury processes such as thalamic degen-
eration.
Conclusion
In conclusion, this is the first report to indicate the unique
neuroinflammatory time course profile of a penetrating
ballistic-like injury to the brain. The acute neuroinflam-
matory response occurred very rapidly post-injury with a
peak upregulation of inflammatory genes occurring on
the order of several hours before that reported for similar
responses in focal ischemic injury models. Glial reactivity
surrounding the primary lesion, as indicated from the
presence of highly ramified and strongly immunoreactive
cell morphologies, occurred earlier for astrocytes (i.e. 6–
24 h post-injury) as compared to microglia (i.e. 72 h post-
injury). A similar but delayed gliotic response was also
observed in the thalamus. In fact, a strong astrocyte
response (i.e. GFAP reactivity) in the thalamus at 72 h cor-
responded to extensive fiber degeneration observed at day
7 post-injury indicating that GFAP may be a useful marker
for predicting an impending degeneration of tissue fibers
in the brain.
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